News
Rhythm and bleughs: how changes in our stomach’s rhythms steer us away from disgusting sights
Disgust is a natural response to unpleasant sights, but for some people, disgust can become pathological, affecting their mental health and quality of life.Read more
Addenbrooke’s specialist endocrinology services ranked best in UK
In their annual specialist hospital rankings, Newsweek has rated the specialist diabetes and endocrinology services at Addenbrooke’s Hospital as the best in the UK, and 20th internationally. Patients attending clinics through this service Read more
Tiny golden bullets could help tackle asbestos-related cancers
Gold nanotubes – tiny hollow cylinders one thousandth the width of a human hair – could be used to treat mesothelioma, a type of cancer caused by exposure to asbestos.Read more
‘Mini-lungs’ reveal early stages of SARS-CoV-2 infection
To better understand how SARS-CoV-2 infects the lungs and causes disease, a team of scientists from the UK and South Korea turned to organoids – ‘mini-organs’ grown in three dimensions to mimic the behaviour of tissue and organs.Read more
Supporting research at Cambridge University Hospitals
As the COVID-19 situation develops, research staff at CUH continue our support of COVID-19 research studies, including Urgent Public Health Studies (UPH), while maintaining safe recruitment to existing open studies. Read more
Early care for people with psychosis supports recovery
A study with an early intervention mental health service has found that sixty percent of people cared for in their first episode of psychosis recovered well.Read more
Funding award to develop minimally invasive tools to improve cancer surgery
A device to help treat tumours in the liver has received a £1 million Government grant.Read more
New model predicts oesophageal cancer eight years early for one in two patients
DNA from tissue biopsies taken from patients with Barrett’s oesophagus – a risk factor for oesophageal cancer – could show which patients are most likely to develop the disease eight years before diagnosis.Read more
Gold medal for Professor Gordon Dougan
Professor Gordon Dougan has been awarded the Albert B. Sabin Gold Medal. The award is given to a distinguished member of the global health community who has made extraordinary contributions to vaccinology or a complementary field.Read more
Transgender and gender-diverse individuals are more likely to be autistic and report higher autistic traits
Transgender and gender-diverse adults are three to six times more likely as cisgender adults to be diagnosed as autistic, according to a new Cambridge study.Read more
New NHS service enables people to sign up to be contacted for COVID-19 vaccine studies
A new NHS service has been launched, helping people across the UK sign up for information on the new COVID-19 vaccine trials.Read more
Sponge on a string test to transform oesophageal cancer diagnosis
A ‘sponge on a string’ pill test can identify ten times more people with Barrett’s oesophagus than the usual GP route, according new research. Read more
New funding boost to speed up diagnosis in oesophageal cancer
Cambridge will lead on improving early detection in oesophageal cancer as part of a Government backed projectRead more
National research platform launches new website
The address is the same, but the next time you visit the NIHR BioResource website, you’ll see it has a brand new look, ready for researchers and the public.Read more
Phased re-start of non-COVID-19 research
In line with NIHR guidance, we are beginning the process of phased re-opening of some non-COVID-19 research studies, while maintaining our contribution to local and nationally prioritised urgent public health studies for COVID-19.Read more
POPStar study launches to investigate how pregnancy data can predict future health
A new study from the Departments of Obstetrics & Gynaecology and Paediatrics at the University of Cambridge is investigating how conditions in the womb can predict the future health of mothers and their children.Read more
Prestigious fellowship election for NIHR Cambridge BRC researchers
The NIHR Cambridge BRC is delighted that three of our researchers have been elected as Fellows of the Academy of Medical Sciences.Read more
Cambridge trial targets immune response to treat COVID-19 patients
A new national study, supported by the NIHR Cambridge Biomedical Research Centre and the Cambridge Clinical Trials Unit will test whether two drugs that are already in use to treat other immune-related conditions Read more
Over 150 participants recruited to new COVID-19 research programme
A “library” of valuable biological samples from people with COVID-19, which will help scientists globally fight the virus, has recruited its 150th participant.Read more
Genetic analysis reveals new causes of Primary Immunodeficiency (PID)
A UK-wide research collaboration through the National Institute for Health Research (NIHR) BioResource for Rare Diseases has combined whole genome sequencing (WGS) with a statistical program called BeviMed to predict the existence of disease-causing changes in the DNA of people with Primary Immunodeficiency (PID). Read more